Related Experiment Videos
Multimodality therapy of esophageal cancer
1General Thoracic Surgery, Massachusetts General Hospital, Boston 02114, USA. wright.cameron@mgh.harvard.edu
Chest
|January 5, 2000
Abstract:
Multimodality therapy of esophageal cancer has been evaluated in several clinical trials, with positive results in terms of improved survival compared with single-modality therapy. A case report is presented describing the use of paclitaxel in a multimodality regimen for a patient with a bulky esophageal tumor. In addition, results are described of a clinical trial in which patients received a paclitaxel-based regimen as part of multimodality therapy for esophageal cancer.